These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1018 related items for PubMed ID: 12344620

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Not FDA-approved, but experts recommend Depo-Provera.
    Contracept Technol Update; 1992 Jan; 13(1):1-7. PubMed ID: 12343458
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Depo Provera: still controversial.
    Wren LM.
    Int Health News; 1988 Feb; 9(2):2-3, 8. PubMed ID: 12179873
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Injectable contraception: the USA perspective.
    Kaunitz AM.
    IPPF Med Bull; 1992 Dec; 26(6):1-3. PubMed ID: 12346920
    [Abstract] [Full Text] [Related]

  • 8. FDA advisory panel recommends approval for Depo-Provera.
    Contracept Technol Update; 1992 Oct; 13(10):159-60. PubMed ID: 12344726
    [Abstract] [Full Text] [Related]

  • 9. Controversy over Depo-Provera.
    Wash Drug Device Lett; 1977 Jan 03; 9(1):2. PubMed ID: 12335988
    [Abstract] [Full Text] [Related]

  • 10. Injectable contraception.
    International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP.
    IPPF Med Bull; 1980 Dec 03; 14(6):1-3. PubMed ID: 12310087
    [Abstract] [Full Text] [Related]

  • 11. What is breast cancer risk with Depo-Provera?
    Contracept Technol Update; 1992 Jan 03; 13(1):15-6. PubMed ID: 12343459
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Depo Provera. Position paper on clinical use, effectiveness and side effects.
    Bigrigg A, Evans M, Gbolade B, Newton J, Pollard L, Szarewski A, Thomas C, Walling M.
    Br J Fam Plann; 1999 Jul 03; 25(2):69-76. PubMed ID: 10454658
    [Abstract] [Full Text] [Related]

  • 16. 3-month contraceptive injection approved.
    FDA Med Bull; 1993 Mar 03; 23(1):6-7. PubMed ID: 12318115
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Researcher explains status of Depo Provera. [Answer to question of Marienetta Blackwell].
    Greenspan A.
    Contracept Technol Update; 1981 Mar 03; 2(3):35-6. PubMed ID: 12337540
    [Abstract] [Full Text] [Related]

  • 19. Medicolegal issues surrounding Depo-Provera easily overcome.
    Contracept Technol Update; 1992 Jan 03; 13(1):16, 18. PubMed ID: 12343460
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 51.